MakCHS Publications

Found 1201 results
Author [ Keyword(Desc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Anti-HIV Agents
D. Cohan, Natureeba, P., Koss, C. A., Plenty, A., Luwedde, F., Mwesigwa, J., Ades, V., Charlebois, E. D., Gandhi, M., Clark, T. D., Nzarubara, B., Achan, J., Ruel, T., Kamya, M. R., and Havlir, D. V., Efficacy and safety of lopinavir/ritonavir versus efavirenz-based antiretroviral therapy in HIV-infected pregnant Ugandan women., AIDS, vol. 29, no. 2, pp. 183-91, 2015.
B. Castelnuovo, Nanyonjo, A., Kamya, M., and Ocama, P., Is it safe to switch from stavudine to zidovudine after developing symptomatic hyperlactatemia?, African health sciences, vol. 8, no. 2, pp. 133-4, 2008.
R. H. Gray, Li, X., Wawer, M. J., Gange, S. J., Serwadda, D., Sewankambo, N. K., Moore, R., Wabwire-Mangen, F., Lutalo, T., and Quinn, T. C., Stochastic simulation of the impact of antiretroviral therapy and HIV vaccines on HIV transmission; Rakai, Uganda., AIDS (London, England), vol. 17, no. 13, pp. 1941-51, 2003.
J. Kagaayi, Dreyfuss, M. L., Kigozi, G., Chen, M. Z., Wabwire-Mangen, F., Serwadda, D., Wawer, M. J., Sewankambo, N. K., Nalugoda, F., Kiwanuka, N., Kiddugavu, M., and Gray, R. H., Maternal self-medication and provision of nevirapine to newborns by women in Rakai, Uganda., Journal of acquired immune deficiency syndromes (1999), vol. 39, no. 1, pp. 121-4, 2005.
R. Colebunders, Moses, K. R., Laurence, J., Shihab, H. M., Semitala, F., Lutwama, F., Bakeera-Kitaka, S., Lynen, L., Spacek, L., Reynolds, S. J., Quinn, T. C., Viner, B., and Mayanja-Kizza, H., A new model to monitor the virological efficacy of antiretroviral treatment in resource-poor countries., The Lancet infectious diseases, vol. 6, no. 1, pp. 53-9, 2006.
E. H. Geng, Neilands, T. B., Thièbaut, R., Bwana, M. Bosco, Nash, D., Moore, R. D., Wood, R., Zannou, D. Marcel, Althoff, K. N., Lim, P. Lian, Nachega, J. B., Easterbrook, P. J., Kambugu, A., Little, F., Nakigozi, G., Nakanjako, D., Kiggundu, V., Li, P. Chung Ki, Bangsberg, D. R., Fox, M. P., Prozesky, H. W., Hunt, P. W., Davies, M. - A., Reynolds, S. J., Egger, M., Yiannoutsos, C. T., Vittinghoff, E. V., Deeks, S. G., and Martin, J. N., CD41 T cell recovery during suppression of HIV replication: an international comparison of the immunological efficacy of antiretroviral therapy in North America, Asia and Africa., Int J Epidemiol, vol. 44, no. 1, pp. 251-63, 2015.
C. Kigonya, Lutwama, F., and Colebunders, R., Extensive hypopigmentation after starting antiretroviral treatment in an human immunodeficiency virus (HIV)-seropositive African woman., International journal of dermatology, vol. 47, no. 1, pp. 102-3, 2008.
Anti-Retroviral Agents
B. Castelnuovo, Byakwaga, H., Menten, J., Schaefer, P., Kamya, M., and Colebunders, R., Can response of a pruritic papular eruption to antiretroviral therapy be used as a clinical parameter to monitor virological outcome?, AIDS (London, England), vol. 22, no. 2, pp. 269-73, 2008.
S. Gianella, Redd, A. D., Grabowski, M. K., Tobian, A. A. R., Serwadda, D., Newell, K., Patel, E. U., Kalibbala, S., Ssebbowa, P., Gray, R. H., Quinn, T. C., and Reynolds, S. J., Vaginal Cytomegalovirus Shedding Before and After Initiation of Antiretroviral Therapy in Rakai, Uganda., J Infect Dis, vol. 212, no. 6, pp. 899-903, 2015.
M. Bwakura-Dangarembizi, Musiime, V., Szubert, A. J., Prendergast, A. J., Gomo, Z. A., Thomason, M. J., Musarurwa, C., Mugyenyi, P., Nahirya, P., Kekitiinwa, A., Gibb, D. M., Walker, A. S., and Nathoo, K., Prevalence of lipodystrophy and metabolic abnormalities in HIV-infected African children after 3 years on first-line antiretroviral therapy., Pediatr Infect Dis J, vol. 34, no. 2, pp. e23-31, 2015.
E. Nakimuli-Mpungu, Musisi, S., Mpungu, S. K., and Katabira, E., Primary mania versus HIV-related secondary mania in Uganda., The American journal of psychiatry, vol. 163, no. 8, pp. 1349-54; quiz 1480, 2006.
B. Castelnuovo, Manabe, Y. C., Kiragga, A., Kamya, M., Easterbrook, P., and Kambugu, A., Cause-specific mortality and the contribution of immune reconstitution inflammatory syndrome in the first 3 years after antiretroviral therapy initiation in an urban African cohort., Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, vol. 49, no. 6, pp. 965-72, 2009.
Antineoplastic Agents
P. G. Richardson, Towards a better understanding of treatment-related peripheral neuropathy in multiple myeloma., The lancet oncology, vol. 11, no. 11, pp. 1014-6, 2010.
Antiretroviral Therapy, Highly Active
B. Castelnuovo, Byakwaga, H., Menten, J., Schaefer, P., Kamya, M., and Colebunders, R., Can response of a pruritic papular eruption to antiretroviral therapy be used as a clinical parameter to monitor virological outcome?, AIDS (London, England), vol. 22, no. 2, pp. 269-73, 2008.
D. Cohan, Natureeba, P., Koss, C. A., Plenty, A., Luwedde, F., Mwesigwa, J., Ades, V., Charlebois, E. D., Gandhi, M., Clark, T. D., Nzarubara, B., Achan, J., Ruel, T., Kamya, M. R., and Havlir, D. V., Efficacy and safety of lopinavir/ritonavir versus efavirenz-based antiretroviral therapy in HIV-infected pregnant Ugandan women., AIDS, vol. 29, no. 2, pp. 183-91, 2015.
J. B. Angel, Hu, Y. - W., Kravcik, S., Tsui, R., Lee, K. H., Barbour, J., Balaskas, E., Branson, B. M., Delwart, E. L., and Grant, R. M., Virological evaluation of the 'Ottawa case' indicates no evidence for HIV-1 superinfection., AIDS (London, England), vol. 18, no. 2, pp. 331-4, 2004.
M. Bwakura-Dangarembizi, Musiime, V., Szubert, A. J., Prendergast, A. J., Gomo, Z. A., Thomason, M. J., Musarurwa, C., Mugyenyi, P., Nahirya, P., Kekitiinwa, A., Gibb, D. M., Walker, A. S., and Nathoo, K., Prevalence of lipodystrophy and metabolic abnormalities in HIV-infected African children after 3 years on first-line antiretroviral therapy., Pediatr Infect Dis J, vol. 34, no. 2, pp. e23-31, 2015.
R. Colebunders, Moses, K. R., Laurence, J., Shihab, H. M., Semitala, F., Lutwama, F., Bakeera-Kitaka, S., Lynen, L., Spacek, L., Reynolds, S. J., Quinn, T. C., Viner, B., and Mayanja-Kizza, H., A new model to monitor the virological efficacy of antiretroviral treatment in resource-poor countries., The Lancet infectious diseases, vol. 6, no. 1, pp. 53-9, 2006.
C. Thorne and Newell, M. - L., Are girls more at risk of intrauterine-acquired HIV infection than boys?, AIDS (London, England), vol. 18, no. 2, pp. 344-7, 2004.
E. Nakimuli-Mpungu, Musisi, S., Mpungu, S. K., and Katabira, E., Primary mania versus HIV-related secondary mania in Uganda., The American journal of psychiatry, vol. 163, no. 8, pp. 1349-54; quiz 1480, 2006.
C. L. Cooper and Cameron, W. D., Interpretation of undetectable hepatitis C virus RNA levels in HIV-hepatitis C virus co-infection., AIDS (London, England), vol. 18, no. 2, pp. 337-8, 2004.
F. Lutwama, Serwadda, R., Mayanja-Kizza, H., Shihab, H. M., Ronald, A., Kamya, M. R., Thomas, D., Johnson, E., Quinn, T. C., Moore, R. D., and Spacek, L. A., Evaluation of Dynabeads and Cytospheres compared with flow cytometry to enumerate CD4+ T cells in HIV-infected Ugandans on antiretroviral therapy., Journal of acquired immune deficiency syndromes (1999), vol. 48, no. 3, pp. 297-303, 2008.
D. Ripamonti, Arici, C., Pezzotti, P., Maggiolo, F., Ravasio, L., and Suter, F., Hepatitis C infection increases the risk of the modification of first highly active antiretroviral therapy in HIV-infected patients., AIDS (London, England), vol. 18, no. 2, pp. 334-7, 2004.

Pages